TGFB1 and idiopathic pulmonary fibrosis: We confirm inhibition of TGF-β1 signaling by EGCG and found multiple downstream likely beneficial effects, such as reduced profibrotic signaling in fibroblasts and reduction in IPF-associated changes in AEC2s.